Exchange: NASDAQ·Updated 07:37 PM EDT
CELU logo

CELU Celularity Inc - Ordinary Shares - Class A

$1.68
$0.15
(8.20%)
Today
Closed $1.68
$0.01
(0.59%)
After Hours
Reported EarningsAug 18
Mkt Cap$48.63M
Vol351,362.00

About CELU

Celularity, Inc. is a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other. The Cell Therapy segment consists of the therapies the company is researching and developing. The BioBanking segment focuses on stem cells from umbilical cords and placentas and provides storage of such cells on behalf of individuals for future use. The Degenerative Disease segment offers products used in surgical and wound care markets. The company was founded by Robert Joseph Hariri Gordon in 2016 and is headquartered in Florham Park, NJ.
46

Neutral Sentiment

How do you feel about CELU?

Advertisement|Remove ads.